September 2018 Issue - Endovascular Today

Table of Contents

Issue

September 2018

Real-World SFA Decision-Making

Contextualizing the current landscape of data and devices.

Supplement

Maximizing Outcomes. Minimizing Burden.

How to React in the SFA

In This Issue

Guest Chief Medical Editors' Page

Real-World SFA Decision-Making

By Marianne Brodmann, MD, and William A. Gray, MD

Cover Stories

Use Caution in Comparing SFA Trial Data

Not all superficial femoral artery device trials are created equal—in fact, none are.

By William A. Gray, MD, and Mario Landini

Roundtable Discussion: Surveying the Landscape: SFA Drug Delivery Trial Designs and Data

Experts discuss key elements of SFA trials, whether a global algorithmic approach to treating SFA disease is possible, and the limitations of cross-trial platform comparisons.

Moderator: William A. Gray, MD
Panel: Gary M. Ansel, MD; Koen Deloose, MD; Michael R. Jaff, DO; and Peter A. Schneider, MD

SPEED: A New Initiative in Real-World PAD Evidence Evaluation

An overview of the FDA's new multistakeholder project to support real-world evidence evaluation for devices aimed at treating peripheral artery disease.

By Misti Malone, PhD

Separating Regulatory and Clinical Standards

Understanding the FDA device approval process and the difference between data from premarket and postapproval trials to make informed clinical decisions.

By Gary M. Ansel, MD, and Raghu Kolluri, MD, RVT, RPVI

Challenges Facing Current and Next-Generation SFA Technologies

A discussion of anatomic barriers to treatment, evolving trial designs, and the impact of reimbursement.

By Krishna Rocha-Singh, MD

Roundtable Discussion: SFA Vessel Prep in the Real World

A discussion on the current role of vessel preparation, when to use it and when not to use it, device selection, and data related to cost-effectiveness and algorithm creation.

Moderator: Marianne Brodmann, MD
Panel: Ehrin J. Armstrong, MD; Lawrence A. Garcia, MD; Gunnar Tepe, MD; Jos C. van den Berg, MD, PhD; and Thomas Zeller, MD

Options for In-Stent Restenosis in 2018

Capabilities and limitations of current technologies and available data.

By Brian G. DeRubertis, MD, FACS

Bioresorbable Stent Technology for Femoropopliteal Disease Treatment: Where Do We Stand?

Appraising the current literature on bioresorbable technology use in the SFA, what can be learned from the coronary experience, and the future of bioresorbable stents in this anatomy.

By Sabine Steiner, MD; Andrej Schmidt, MD; and Dierk Scheinert, MD

Transforming Open to Endo: Percutaneous Bypass as an Option for Long-Segment SFA Disease

A brief review of the Detour procedure technique, proposed advantages, and potential clinical applications.

By James D. Joye, DO, FACC, FSCAI

Featured Technology

September 2018 Supplement

Maximizing Outcomes. Minimizing Burden.

How to React in the SFA

In This Issue

September 2018 Supplement

Most Read Articles